- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 04A: N,N'-[sulfanediylbis(ethane-2,1-diyl-1,3,4-thiadiazole-5,2-diyl)]bis(2-phenylacetamide)(Non-covalent)
- 8 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 4 residues within 4Å:- Chain A: F.155, S.156, N.157, A.158
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:S.156, A:N.157, A:A.158
SO4.3: 4 residues within 4Å:- Chain A: Y.176, K.180
- Chain B: K.102, R.169
5 PLIP interactions:3 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:Y.176
- Water bridges: A:K.180
- Salt bridges: A:K.180, B:K.102, B:R.169
SO4.5: 4 residues within 4Å:- Chain B: F.155, S.156, N.157, A.158
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.156, B:N.157, B:A.158
SO4.6: 4 residues within 4Å:- Chain A: K.102, R.169
- Chain B: Y.176, K.180
6 PLIP interactions:2 interactions with chain A, 4 interactions with chain B- Salt bridges: A:K.102, A:R.169, B:K.180
- Hydrogen bonds: B:Y.176, B:Y.176
- Water bridges: B:K.180
SO4.8: 4 residues within 4Å:- Chain C: F.155, S.156, N.157, A.158
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:S.156, C:N.157, C:A.158
SO4.9: 4 residues within 4Å:- Chain C: Y.176, K.180
- Chain D: K.102, R.169
5 PLIP interactions:2 interactions with chain D, 3 interactions with chain C- Salt bridges: D:K.102, D:R.169, C:K.180
- Hydrogen bonds: C:Y.176
- Water bridges: C:K.180
SO4.11: 4 residues within 4Å:- Chain D: F.155, S.156, N.157, A.158
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:S.156, D:N.157, D:A.158
SO4.12: 4 residues within 4Å:- Chain C: K.102, R.169
- Chain D: Y.176, K.180
6 PLIP interactions:2 interactions with chain C, 4 interactions with chain D- Salt bridges: C:K.102, C:R.169, D:K.180
- Hydrogen bonds: D:Y.176, D:Y.176
- Water bridges: D:K.180
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Thangavelu, K. et al., Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism. Proc.Natl.Acad.Sci.USA (2012)
- Release Date
- 2012-06-13
- Peptides
- Glutaminase kidney isoform, mitochondrial: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 04A: N,N'-[sulfanediylbis(ethane-2,1-diyl-1,3,4-thiadiazole-5,2-diyl)]bis(2-phenylacetamide)(Non-covalent)
- 8 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Thangavelu, K. et al., Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism. Proc.Natl.Acad.Sci.USA (2012)
- Release Date
- 2012-06-13
- Peptides
- Glutaminase kidney isoform, mitochondrial: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A